Marvel Biosciences Corp (MRVL) — Financial Flexibility Index
Marvel Biosciences Corp (MRVL) has a Financial Flexibility Index of -0.04x as of October 2025. Free cash flow of CA$-178.46K (operating CF CA$-178.46K minus capex CA$0.00) represents 0% of total liabilities (CA$4.33 Million). Check MRVL capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Marvel Biosciences Corp Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Marvel Biosciences Corp across 6 annual periods. See working capital to net assets of Marvel Biosciences Corp to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Marvel Biosciences Corp (2020–2025)
Year-by-year free cash flow to debt coverage for Marvel Biosciences Corp. For the full company profile including market capitalisation, see how much is Marvel Biosciences Corp worth.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | CA$-1.15 Million | CA$-1.15 Million | CA$4.33 Million | ▲ +25.3% |
| 2024 | -0.36x | CA$-1.18 Million | CA$-1.18 Million | CA$3.32 Million | ▲ +36.1% |
| 2023 | -0.56x | CA$-1.33 Million | CA$-1.33 Million | CA$2.39 Million | ▲ +81.8% |
| 2022 | -3.06x | CA$-2.19 Million | CA$-2.19 Million | CA$718.00K | ▲ +74.9% |
| 2021 | -12.19x | CA$-1.37 Million | CA$-1.37 Million | CA$112.48K | ▼ -300.9% |
| 2020 | -3.04x | CA$-538.53K | CA$-538.53K | CA$177.18K | — |